Stay updated on Galcanezumab in Chronic Migraine Ages 12-17 Clinical Trial

Sign up to get notified when there's something new on the Galcanezumab in Chronic Migraine Ages 12-17 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Galcanezumab in Chronic Migraine Ages 12-17 Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The revision label in the page footer updates from v3.6.2 to v3.6.3. This reflects a minor site update without altering study data or page functionality.
    Difference
    0.0%
    Check dated 2026-07-03T23:58:24.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The page shows Revision: v3.6.2, replacing the previous v3.6.0, indicating a small site update; the study history information remains unchanged.
    Difference
    0.0%
    Check dated 2026-06-27T01:20:58.000Z thumbnail image
  3. Check
    14 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Version history shows a new revision v3.6.0 replacing v3.5.5. A note has been added stating the study is no longer looking for participants.
    Difference
    0.2%
    Check dated 2026-06-12T14:50:30.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The footer now shows Revision: v3.5.5, replacing Revision: v3.5.4, indicating a new site release.
    Difference
    0.0%
    Check dated 2026-06-05T09:53:06.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The record history now shows Revision: v3.5.4 added, replacing the previous v3.5.3 to reflect a new release tag.
    Difference
    0.0%
    Check dated 2026-05-15T03:04:59.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The page’s display revision was updated from v3.5.2 to v3.5.3, reflecting a site/version update rather than any modification to the clinical trial record itself.
    Difference
    0.0%
    Check dated 2026-04-23T21:57:05.000Z thumbnail image

Stay in the know with updates to Galcanezumab in Chronic Migraine Ages 12-17 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Galcanezumab in Chronic Migraine Ages 12-17 Clinical Trial page.